share_log

藥師幫：截至2024年12月31日止年度年度業績公告

YSB: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2024

HKEX ·  Mar 17 13:35

Summary by Moomoo AI

藥師幫2024年度實現營收人民幣179.04億元，同比增長5.5%；毛利18.13億元，同比增長4.2%；本公司擁有人應佔利潤3001.3萬元，扭轉去年虧損；經調整淨利潤1.57億元，同比增長20.1%。公司首次派發末期股息每股人民幣0.075元。集團自營業務收入169.73億元，同比增長5.8%，主要受益於買家群體擴大及物流服務優化。平台業務收入8.81億元，同比增長0.9%，平台佣金率由3.2%提升至3.3%。期內，月均活躍買家數43.3萬家，同比增長18%；付費買家數40.1萬家，佔比達92.7%。公司持續深化數字化轉型，推出「光譜小屋」基層智慧醫療解決方案，並完成收購一塊醫藥100%股權。展望2025年，公司將進一步深化與產業鏈各環節協同合作，推動院外醫藥產業數字化升級，助力實現醫藥資源普惠可及。
藥師幫2024年度實現營收人民幣179.04億元，同比增長5.5%；毛利18.13億元，同比增長4.2%；本公司擁有人應佔利潤3001.3萬元，扭轉去年虧損；經調整淨利潤1.57億元，同比增長20.1%。公司首次派發末期股息每股人民幣0.075元。集團自營業務收入169.73億元，同比增長5.8%，主要受益於買家群體擴大及物流服務優化。平台業務收入8.81億元，同比增長0.9%，平台佣金率由3.2%提升至3.3%。期內，月均活躍買家數43.3萬家，同比增長18%；付費買家數40.1萬家，佔比達92.7%。公司持續深化數字化轉型，推出「光譜小屋」基層智慧醫療解決方案，並完成收購一塊醫藥100%股權。展望2025年，公司將進一步深化與產業鏈各環節協同合作，推動院外醫藥產業數字化升級，助力實現醫藥資源普惠可及。
In 2024, YSB achieved revenue of 17.904 billion yuan, a year-on-year increase of 5.5%; gross profit was 1.813 billion yuan, a year-on-year increase of 4.2%; profit attributable to the company's shareholders was 30.013 million yuan, reversing last year's loss; adjusted net profit was 0.157 billion yuan, a year-on-year increase of 20.1%. The company distributed its first final dividend of 0.075 yuan per share.The group's self-operated business revenue was 16.973 billion yuan, a year-on-year increase of 5.8%, mainly benefiting from the expansion of the buyer base and optimization of Logistics services. Platform business revenue was 0.881 billion yuan, a year-on-year increase of 0.9%, with the platform commission rate increasing from 3.2% to 3.3%. During this period, the average number of active...Show More
In 2024, YSB achieved revenue of 17.904 billion yuan, a year-on-year increase of 5.5%; gross profit was 1.813 billion yuan, a year-on-year increase of 4.2%; profit attributable to the company's shareholders was 30.013 million yuan, reversing last year's loss; adjusted net profit was 0.157 billion yuan, a year-on-year increase of 20.1%. The company distributed its first final dividend of 0.075 yuan per share.The group's self-operated business revenue was 16.973 billion yuan, a year-on-year increase of 5.8%, mainly benefiting from the expansion of the buyer base and optimization of Logistics services. Platform business revenue was 0.881 billion yuan, a year-on-year increase of 0.9%, with the platform commission rate increasing from 3.2% to 3.3%. During this period, the average number of active buyers per month was 0.433 million, a year-on-year increase of 18%; the number of paid buyers was 0.401 million, accounting for 92.7%. The company continues to deepen its digital transformation by launching the "Spectrum Cabin" primary smart Medical solution, and has completed the acquisition of a 100% stake in a pharmaceutical company. Looking ahead to 2025, the company will further deepen collaborative cooperation with various segments of the Industry Chain to promote the digital upgrade of the out-of-hospital medical industry, helping to achieve the accessibility of Medical resources.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 263

Recommended

Related Stocks Related Stocks
Symbol Mini Chart Price
NEW RAY MEDIC
06108
0.050
KINGWORLD
01110
0.465
UNI HEALTH
02211
0.153
SH PHARMA
02607
11.660
JD HEALTH
06618
33.600
Log In for the Full List
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
Fed rate cut expectations for 2025 intensify. What’s your market outlook?
43%
57%
Bullish
Bearlish
1578 votes
FOMC Press Conference, March 19, 2025

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
OK